Polsinelli provides public policy counsel to health care clients that is grounded in its deep understanding of the health care industry as well as the regulatory and statutory framework that continues to significantly affect the industry on the whole.

Supported by highly experienced senior policy advisers, our public policy team partners with our national health care practice to provide strong advocacy to health care clients at the state and federal levels.

With a focus on advancing clients’ legislative and policy objectives, our firm has become intimately familiar with all aspects of the federal reform law including implementation at the state level. We also have experience working with the Centers for Medicare and Medicaid Services and Health and Human Services on the interpretation and amendment of a wide variety of health care regulations. Our public policy attorneys also have first-hand knowledge of the inner workings of the various state and federal agencies that impact the health care industry on a daily basis. Our experience includes:

  • Forming coalitions of provider groups to leverage interests and effectuate regulatory change or to challenge regulations and statutes
  • Lobbying for revised interpretations of regulations adversely affecting our health care clients
  • Lobbying for coverage decisions under Medicare
  • Drafting and submitting grant applications on behalf of our health care clients

Whether at the national level working with executive agencies or the White House or at the local level collaborating with city, county and state governments, our team focuses on maintaining a full understanding of the legislative and regulatory environment while also maintaining relationships with key decision makers that can be integral to achieving a health care organization’s objectives.

Related Capabilities
Health CarePublic Policy
Publications
All Publications
Beyond the Pump: The Iran War’s Adverse Impact on U.S. Health Care
Key Takeaways The closure of the Strait of Hormuz following the U.S.-Iran conflict is disrupting global health care supply chains and increasing costs for critical medical products. Shortages and delays are already affecting pharmaceuticals, MRI-related helium supplies and cold-chain products. The disruptions create operational and financial pressure for health care providers that depend on imported drugs, medical equipment and time-sensitive supplies. Rising freight, fuel and insurance costs are contributing to higher prices and longer lead times across multiple product categories. Health care organizations should closely monitor supply availability, transportation delays and pricing volatility tied to the ongoing conflict and shipping restrictions. Providers may need to evaluate inventory levels, supplier diversification and contingency planning for critical medical inputs. Since the beginning of the United States’
Read More
Election Year Politics and Policy at CMMI: What Stakeholders Can Expect
Key Takeaways CMS’ Innovation Center is accelerating new payment and care delivery models as the Trump administration uses CMMI to advance health policy priorities. Current models target areas such as chronic care, behavioral health, drug pricing and value-based care. CMMI remains a powerful policy vehicle, but its recent pace has drawn renewed scrutiny over cost savings, scale and taxpayer value. That debate could shape oversight, legislation and expectations for how future models are designed and evaluated. Health care stakeholders should continue tracking CMMI closely as participation opportunities expand and mandatory models create new operational demands. Organizations should assess where engagement, compliance planning or advocacy may be needed as models evolve. The Centers for Medicare & Medicaid Services (CMS) is currently pursuing approximately 35 models
Read More